Login

Virginie Morgon Unveils Eurazeo's September Initiatives | Virginie Morgon, CEO, Eurazeo. 00:10:00

Share On Facebook Share On Twitter

Eurazeo's Latest Update: Virginie Morgon, September Highlight

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Fintech VC Powerhouse & Penetrating|Mike Packer,Partner,QED Investors
00:10:00
Mock Interview at Jane Street: A Guide to Their Process and Tips
00:10:00
Beacon Financial: Emphasizing Values and Comfort in a Female-Led Advisory Firm
00:10:00
Explore Career Opportunities with Us
00:10:00
The Symbols of Broad-Based Specialization Distinct ETFs for investors advanced needs|Amy Oldenburg,Head,Emerging Markets Equity
00:10:00
Unveiling eToro: A Decade of Financial Innovation | Yoni Assia , CEO, eToro.
00:10:00
Mike Speetzen, Polaris CEO, discusses investor day, earnings, and the state of high-ticket consumers on 'Closing Bell: Overtime'.|Jae-Ho Kim is Director & Head-Management Support at Polaris Office Corp.
00:10:00
Victor Cantore Discusses Vision Lithium's Progress and Strategic Advantages in the Quebec Lithium Sector at One-to-One Conference
00:10:00
500 million seed-stage venture firm that commits early|Jeff Clavier,Founder and Managing Partner,Uncork Capital
00:10:00
Next Target for Antibe Therapeutics' Proprietary Hydrogen Sulfide Platform: Inflammatory Bowel Disease (IBD)|Dan Legault, CEO, Antibe Therapeutics Inc.
00:10:00
B2Gold Discusses Namibia Gold Project and Global Exploration Plans
00:10:00
India's Economic Evolution: From FX Crisis to Surplus, Digital Revolution, and Infrastructure Growth | Nilesh Shah, CEO , Kotak Mutual Fund.

© 2017 - Neuhu+